Marker Therapeutics, Inc. MRKR
NASDAQ · United States · Health Technology
$1.050.00 (0.00%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 2026-08-14 | -0.09 | -0.13 | +29.1% | $700.00K | +6.0% | +4.5%$1.11→$1.16 |
| Q1 2026 | 2026-05-15 | -0.16 | -0.19 | +15.8% | — | — | -4.8%$1.46→$1.39 |
| Q4 2025 | 2026-03-18 | -0.04 | -0.19 | +78.9% | — | — | -2.9%$1.36→$1.32 |
| Q3 2025 | 2025-11-13 | -0.12 | -0.69 | +82.6% | — | — | -2.1%$0.94→$0.92 |
| Q4 2024 | 2025-03-31 | -0.42 | -0.22 | -90.9% | — | — | — |
| Q1 2024 | 2024-05-15 | -0.27 | -0.25 | -8.0% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.